1 Min Read
July 10 (Reuters) - BioInvent International AB
* Bioinvent and Thrombogenics amending long-standing monoclonal antibody development agreement Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.